Empros Pharma participates in Bio Korea

CEO Arvid Söderhäll participated in at the Bio-Korea conference in Seoul in May. South Korea represents a vibrant region with an impressive traction. Empros Pharma has established contacts with investors, pharmaceutical industry, key opinion leaders, regulatory authority as well as consultants....


Pressrelease Phase 2a trial

Swedish Start-Up Pharma reveals positive Phase 2a trial - results from a novel oral medication treatment of obesity  The Swedish Pharmaceutical start-up Empros Pharma AB has new clinical results from a Phase 2a trial of its first novel and unique product EMP16; an oral drug for...